Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease
Orlikowski D, Pellegrini N, Prigent H, Laforêt P, Carlier R, Carlier P, Eymard B, Lofaso F, Annane D.
Neuromuscul Disord. 2011. 21(7):477-82.
This open-label prospective exploratory study investigated the effect of 12 months of recombinant enzyme replacement therapy in 5 adult patients with severe Pompe disease.
Motor and respiratory function, quantitative muscle testing and spirometry were assessed. Concerning motor function assessed by MFM, 3 patients, wheelchair bound at baseline, improved sitting and proximal motor function and 2 patients improved in their ability to stand and transfer.
Alglucosidase alfa may stabilize or even slightly improve muscle strength and respiratory function among patients with severe Pompe disease.
Keywords: Pompe disease; Alglucosidase alfa; Enzyme replacement therapy; rhGAA
Articles dans les revues scientifiques
Evaluation of muscle oxygenation by near-infrared spectroscopy in patients with Becker muscular dystrophy
Allart E, Olivier N, Hovart H, Thevenon A, Tiffreau V. Neuromuscul Disord. 2012. 22(8): 720-7. The primary objective of the study was to describe and compare muscle oxygenation patterns during constant-load exercise in patients with Becker Muscular Dystrophy (BMD) and...
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients.
D'Angelo MG, Gandossini S, Martinelli Boneschi F, Sciorati C, Bonato S, Brighina E, Comi GP, Turconi AC, Magri F, Stefanoni G, Brunelli S, Bresolin N, Cattaneo D, Clementi E. Pharmacol Res. 2012. 65(4): 472-9. The main of this monocentric pilot study was to evaluate...
Gait Assessment in Children With Duchenne Muscular Dystrophy During Long-Distance Walking
Ganea R, Jeannet PY, Paraschiv-Ionescu A, Goemans N, Piot C, Van den Hauwe M, Aminian K. J Child Neurol. 2012. 27: 1 30-38. Gait patterns of 25 children with Duchenne muscular dystrophy were compared to that of healthy children. Authors showed that Duchenne muscular...
Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy.
Silva EC, Machado DL, Resende MB, Silva RF, Zanoteli E, Reed UC. Arq Neuropsiquiatr. 2012. 70(3): 191-5. Description of the evolution of the motor function of 33 DMD patients (27 ambulant and 6 non ambulant at inclusion) treated with steroids during 18 month assessed...
Quantitative MRI can detect subclinical disease progression in muscular dystrophy.
Fischmann A, Hafner P, Fasler S, Gloor M, Bieri O, Studler U, Fischer D. J Neurol. 2012. 259(8): 1648-54. The aim of this study was to compare different methods of quantitative and semiquantitative MRI in order to validate clinical parameters for the follow-u of...
The assisted 6-minute cycling test to assess endurance in children with a neuromuscular disorder.
Jansen M, De Jong M, Coes HM, Eggermont F, Van Alfen N, De Groot IJ. Muscle Nerve. 2012. 46(4): 520-3. Development of the "assisted 6-minute cycling" aiming to assess DMD patients' endurance.MFM is use as a gold standard.PubMed linkKeywords: Assisted 6-minute cycling...